These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6296289)

  • 21. Histological study of the progression of herpes simplex virus in mice.
    Lascano EF; Berria MI
    Arch Virol; 1980; 64(1):67-79. PubMed ID: 6246857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of herpes simplex virus infection in cervical ganglia of mice.
    Nicholls SM; Blyth WA
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1779-88. PubMed ID: 2472466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Ohtomo N; Hayashi Y; Yamamoto M; Mori R
    Microbiol Immunol; 1985; 29(2):143-9. PubMed ID: 2989659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraneural localisation of herpes simplex virus in latently infected guinea pigs.
    Scriba M
    Nature; 1977 Jun; 267(5611):529-31. PubMed ID: 195220
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity.
    Bonneau RH; Jennings SR
    J Virol; 1989 Mar; 63(3):1480-4. PubMed ID: 2536848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissemination of herpes simplex virus in ganglia after footpad inoculation in neurectomized and non-neurectomized mice.
    Klein RJ; DeStefano E
    Arch Virol; 1983; 77(2-4):231-8. PubMed ID: 6314936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does restriction enzyme analysis reveal changes in herpes simplex virus DNA after latency in mouse ganglia?
    Wolff MH; Krämer S; Schneweis KE
    Microbiologica; 1986 Apr; 9(2):139-45. PubMed ID: 3012286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report.
    von Rheinbaben F; Schneweis KE
    Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent genital Herpes simplex virus (HSV) infection of guinea pigs.
    Scriba M
    Med Microbiol Immunol; 1976 Dec; 162(3-4):201-8. PubMed ID: 187918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.
    Openshaw H; Asher LV; Wohlenberg C; Sekizawa T; Notkins AL
    J Gen Virol; 1979 Jul; 44(1):205-15. PubMed ID: 227991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent stability of herpes simplex virus genomes isolated from primary and recurrent infections and dorsal root ganglia in the mouse.
    Blondeau JM; Embil JA; McFarlane ES
    J Med Microbiol; 1988 Dec; 27(4):291-6. PubMed ID: 2848947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
    Subak-Sharpe JH; Al-Saadi SA; Clements GB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro reactivation of latent herpes simplex virus by the demethylating compound hexamethylene-bis-acetamide.
    Blondeau JM; Aoki FY
    J Virol Methods; 1992 Dec; 40(3):323-9. PubMed ID: 1335458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.
    MacLean A; Robertson L; McKay E; Brown SM
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2305-10. PubMed ID: 1654382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
    Al-Saadi SA; Gross P; Wildy P
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of lymphatic and hematologic spreading as a pathogenic condition for neural persistence of herpes simplex virus].
    Gerritzen A; Schneweis KE
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):559-69. PubMed ID: 2837877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus.
    Walz MA; Yamamoto H; Notkins AL
    Nature; 1976 Dec; 264(5586):554-6. PubMed ID: 1004594
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed IgG-mediated clearance of herpes simplex virus type 1 from the CNS but not footpad during the early stages of infection: possible result of relative integrity of the blood-brain barrier.
    McKendall RR
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1965-72. PubMed ID: 6310036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2.
    Caspary L; Schindling B; Dundarov S; Falke D
    Arch Virol; 1980; 65(3-4):219-27. PubMed ID: 6251783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.